Can patient-reported measurements of pain be used to improve cancer pain management? A systematic review and meta-analysis by Adam, R. et al.
This is an author produced version of Can patient-reported measurements of pain be used
to improve cancer pain management? A systematic review and meta-analysis.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/128544/
Article:
Adam, R., Burton, C.D. orcid.org/0000-0003-0233-2431, Bond, C.M. et al. (2 more 
authors) (2017) Can patient-reported measurements of pain be used to improve cancer 
pain management? A systematic review and meta-analysis. BMJ Supportive and Palliative 
Care, 7. pp. 373-382. ISSN 2045-435X 
https://doi.org/10.1136/bmjspcare-2016-001137
promoting access to
White Rose research papers
eprints@whiterose.ac.uk
http://eprints.whiterose.ac.uk/
Can patient-reported measurements
of pain be used to improve cancer
pain management? A systematic
review and meta-analysis
Rosalind Adam,1 Christopher D Burton,1 Christine M Bond,1
Marijn de Bruin,2 Peter Murchie1
ABSTRACT
Purpose Cancer pain is a distressing and
complex experience. It is feasible that the
systematic collection and feedback of patient-
reported outcome measurements (PROMs)
relating to pain could enhance cancer pain
management. We aimed to conduct a systematic
review of interventions in which patient-reported
pain data were collected and fed back to
patients and/or professionals in order to improve
cancer pain control.
Methods MEDLINE, EMBASE and CINAHL
databases were searched for randomised and
non-randomised controlled trials in which
patient-reported data were collected and fed
back with the intention of improving pain
management by adult patients or professionals.
We conducted a narrative synthesis. We also
conducted a meta-analysis of studies reporting
pain intensity.
Results 29 reports from 22 trials of 20
interventions were included. PROM measures
were used to alert physicians to poorly controlled
pain, to target pain education and to link
treatment to management algorithms. Few
interventions were underpinned by explicit
behavioural theories. Interventions were
inconsistently applied or infrequently led to
changes in treatment. Narrative synthesis
suggested that feedback of PROM data tended
to increase discussions between patients and
professionals about pain and/or symptoms
overall. Meta-analysis of 12 studies showed a
reduction in average pain intensity in intervention
group participants compared with controls
(mean difference=−0.59 (95% CI −0.87 to
−0.30)).
Conclusions Interventions that assess and
feedback cancer pain data to patients and/or
professionals have so far led to modest
reductions in cancer pain intensity. Suggestions
are given to inform and enhance future PROM
feedback interventions.
INTRODUCTION
Pain is the most frequent complication of
cancer.1 Approximately 40% of patients
experience moderate-to-severe pain at
diagnosis, rising to 70% at the end of
life.1 Cancer pain control is frequently
suboptimal, despite effective treatments
being available.2 Under-reporting of pain
by patients, inadequate communication
about pain between patients and health-
care professionals, and inadequate assess-
ment of pain by professionals are known
to contribute to poor pain control.3 4
Traditional clinical consultation models
rely on a question and answer-based dialo-
gue between the patient and professional
during which patients are prompted to
report and describe problems. This may
underestimate pain for several reasons.
Retrospective reports by patients are
subject to recall bias, underestimation and
imprecision.5 Patients may fail to report
cancer pain if they expect that pain is an
inevitable consequence of cancer, if they
believe that pain is a useful indicator of
disease activity, or if they fear that
symptom discussions will shift the profes-
sional’s focus away from the treatment of
disease.6 Pain can be a complex and sub-
jective experience, and patients can have
difficulties judging the validity of pain as a
presenting symptom that warrants
medical attention.7 Professionals may not
ask about or adequately assess the details
of the patient’s pain.8 Therefore, it is pos-
sible that the traditional consultation
model could lead to specific deficiencies
in cancer pain management.
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The potential value of collecting patient-reported
outcome measurements (PROMs) is increasingly being
recognised in clinical practice.9 PROMs are defined as:
‘measurements of any aspect of a patient’s health status
that come directly from the patient, without interpreta-
tion of the patient’s response by a clinician or anyone
else’.10 Patient-reported outcomes might be collected
from patients via interviews, questionnaires or diaries.
Recently, digital technology has enabled PROMs to be
collected remotely via hand-held devices and web-based
forms. It has been suggested that PROMs might have
value in the provision of patient health status informa-
tion to clinicians; monitoring response to treatments
(and their side effects); detecting unrecognised pro-
blems; and improving health management behaviours
by patients and professionals.11 In oncology, PROMs
have been shown to improve patient satisfaction with
their care and to increase the frequency of discussion of
patient outcomes during consultations.12 13
Despite the impact of pain on the well-being of
patients with cancer and the potential value of using
PROMs to enhance cancer pain management, it is cur-
rently unclear whether PROM interventions can have
an impact on patient pain outcomes. This review aims
to synthesise the evidence on interventions which
have used patient-reported pain measurements to
enhance the management of cancer-related pain by
making these pain data available to patients and/or
healthcare providers; to describe the interventions
and their main components; and to determine
whether the systematic collection of patient reported
pain data can improve cancer pain outcomes.
METHODS
A systematic review was conducted to identify rando-
mised controlled trials (RCTs) and controlled trials of
interventions which involved the systematic collection
of patient-reported measurements of pain related to
cancer or its treatment. The review was conducted
according to ‘the Preferred Reporting Items for
Systematic reviews and Meta-Analyses’ (PRISMA) cri-
teria. A review protocol was registered and is available
at: http://www.crd.york.ac.uk/PROSPEROFILES/15217_
PROTOCOL_20141027.pdf
Inclusion and exclusion criteria
This review considered RCT and non-RCT in which
patient-reported measurements of pain were collected
and fed back to patients and/or clinicians with the inten-
tion of improving cancer pain management behaviours
by adult patients or professionals. It was judged that
non-randomised studies were relevant to the assessment
of PROM intervention components. Inclusion and
exclusion criteria are summarised in table 1.
Search strategy
There were three groups of search terms relating to:
cancer pain; self-report and measurement; and
behavioural change relating to pain management.
Keywords and Boolean operators were explored and
combined on the advice of a senior medical librarian
to search MEDLINE, EMBASE and CINAHL data-
bases from inception. Database searches took place in
November and December 2014 and a MEDLINE
search was updated in December 2015. Detailed
search strategies and dates are shown in online
supplementary appendix 1. Reference lists of two
reviews of PROMs in oncology12 13 and all relevant
full-text papers included in this review were searched
for additional relevant titles.
Study selection
Study titles and then abstracts of relevant titles were
screened independently by two authors (RA and
CMB). Full texts were retrieved for all unique
abstracts which were felt to be potentially relevant by
either author, and these were reviewed independently
against the inclusion and exclusion criteria by two
authors (RA and one of CMB, CDB, PM and MdB).
Any disagreement was resolved by discussion.
Risk of bias assessment
Risk of bias was assessed independently by two
authors (RA and CDB) according to the Cochrane col-
laboration risk of bias tool14 and inter-rater reliability
was assessed using Cohen’s κ statistic,15 calculated on
Stata statistical software V.14.
Data extraction and synthesis
Data extraction was based on the Template for
Intervention Description and Replication (TIDieR)
checklist.16 Study authors were contacted by email
where methodological or outcome data were missing
from papers.
Table 1 Summary of inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
RCTs and controlled intervention
trials. All comparators considered
Non-malignant pain
Adults aged 18 years and over Cancer survivors without active
disease
All cancer types, grades, stages and
prognoses
Pain outcomes reported only within
composite measures of quality of
life or distress scores
Participants experiencing pain
relating to cancer or its treatment
(including anticancer therapies and
surgical procedures) at enrolment, or
who were considered to be at risk
of such pain during the intervention
period
Intervention includes systematic
collection of patient-reported pain
data, alone or in combination with
data on other symptoms or
outcomes
RCT, randomised controlled trial.
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As specified in the protocol, we anticipated hetero-
geneity in interventions and reported outcomes and
so carried out a narrative synthesis of the included
studies. For those studies which reported outcomes
for pain intensity using similar measures, we also con-
ducted a meta-analysis. RevMan V.5 was used for sta-
tistical analysis, with a random-effects model in view
of the clinical heterogeneity of studies.
RESULTS
A PRISMA diagram is shown in figure 1. In total,
3412 titles were identified by searching four databases
and by screening reference lists. No new studies were
identified in the updated MEDLINE search
(December 2015); however, one new article was iden-
tified after the initial database searches17 which was
linked to the research team of an earlier
study.18 Forty-five full-text articles were assessed, of
which 29 satisfied the inclusion and exclusion criteria
and were included in the narrative synthesis.
Characteristics of the included studies
There were 29 reports17–45 of 22 unique trials of 20
interventions. Twenty trials were RCTs, and two were
controlled trials.19 23 The trials were published
between 1997 and 2015 and were conducted in the
USA, the Netherlands, Norway, Canada, Germany
and the UK (table 2). There were 5234 unique trial
participants. Most studies were conducted in an
oncology outpatient setting in patients with mixed
cancer types (table 2).
Risk of bias in included studies
A Cochrane risk of bias summary assessment is shown
in table 3. Inter-rater reliability for risk of bias assess-
ment (κ) between the two reviewers was 0.84 (95%
CI 0.75 to 0.88), suggesting high levels of agreement.
The ‘blinding of participants and personnel’ category
has been omitted from the summary assessment
because the nature of the interventions meant that
none of the included studies could have blinded the
research participants. Only Wilkie et al45 blinded
Figure 1 PRISMA chart detailing study identification and selection process. PRISMA, Preferred Reporting Items for Systematic
reviews and Meta-Analyses.
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Table 2 Summary of studies
Author, publication year,
country, number of
participants (n). Clinical setting Monitoring
PROM feedback mechanism (intervention
group)
Anderson 2015,17 USA, n=60 Outpatient oncology. Breast cancer Automated telephone monitoring
twice weekly for 8 weeks
Oncologist emailed if symptom reached
thresholds. Symptom summaries given to
oncologists before scheduled appointments
Aubin 2006,19 Canada, n=80 Community palliative care. Mixed
cancer types
Twice daily paper diary for
4 weeks
Patient instructed to contact their nurse if pain
or analgesic use reached a set threshold. Nurse
liaised with prescribing physician
Berry 2011,20 USA, n=660
(ESRA-C 1 intervention)
Outpatient oncology. Mixed cancer
types
Preclinic on touch screen
notebook computers on 2
occasions
Colour graphical summaries handed to the
clinician before appointments or attached to
clinical notes
Berry 2014,21 USA, n=752
(ESRA-C 2 intervention)
Outpatient oncology. mixed cancer
types
Internet-based form (completed at
home or on clinic PCs) at 3
points over 8 weeks
Symptoms above a threshold automatically
produced tailored coaching messages on how
to describe the problem to the clinical team.
PROM graphs and coaching messages could be
viewed by the patient at any time
Bertsche 2009,23 Germany,
n=100
Inpatient oncology. Mixed cancer
types
Daily inpatient assessment Pain scores linked to algorithmic pain
management instructions
Cleeland 2011,18 USA,
n=100
Postoperative outpatient. Primary
lung cancer or lung metastases
Twice weekly automated
telephone calls for 4 weeks
An email alert was sent to the advanced nurse
practitioner if any symptoms were above a
threshold.
De Wit 2001,24 the
Netherlands, n=313, and Van
Der Peet,44 2009, the
Netherlands, n=120
Community palliative care. Mixed
cancer types
Twice daily paper pain diary for
2 months
Patient’s knowledge, attitude and pain ratings
used to tailor education and advice about
non-pharmacological strategies
Du Pen 1999,26 USA, n=81 Outpatient oncology. Mixed cancer
types
Daily paper diary for 3 months Pain ratings, side effects and analgesic use
mapped to algorithmic pain management
guidelines for physicians
Given 2004,27 USA, n=237 Outpatient oncology. Mixed cancer
types
Fortnightly report to nurse
(face-to-face and by telephone)
over 20 weeks
Symptoms above a threshold lead the nurse to
provide specific self-management instructions
and coaching
Hoekstra 2006,28 the
Netherlands, n=146
Outpatient oncology. Breast cancer Weekly ratings in a paper booklet Patients were asked to bring the symptom
monitor booklet to all clinical appointments.
Kravitz 2011,29–32 USA,
n=307
Outpatient oncology and palliative
care. Recurrent or metastatic lung,
breast, and upper gastrointestinal
cancers
Questionnaire administered by
telephone by a health educator
on a single occasion prior to a
clinic appointment
Health educator met with patients an hour
before clinic appointments and used their
PROM data to provide tailored pain education,
correcting misconceptions, teaching
self-management strategies and how to
communicate with the physician.
Kroenke 2010,33 USA, n=405 Outpatient oncology. Mixed cancer
types
Automated telephone or online,
twice weekly to monthly over
12 months
Nurse reviewed symptom reports, liaised with
the patient’s oncologist and contacted the
patient with treatment recommendations.
Miaskowski 2004,34 USA,
n=174 and Rustoen 2014,39
Norway, n=179 (PRO-SELF
intervention)
Outpatient oncology. Cancer with
bony metastases
Daily paper diary for 6 weeks PROM data used to tailor education and
coaching. Patients taught to use a weekly pill
box, and to use a specific script to
communicate with their physician about
unrelieved pain and the need for a change in
their medication.
Mooney 2014,35 USA, n=250 Outpatient oncology. Mixed cancer
types
Daily automated telephone
assessment for 45 days
Automated alerts faxed or emailed to the
patient’s oncologist or nurse if symptoms or
trends in symptoms reached a threshold.
Post 2013,36 USA, n=50 Outpatient oncology. Breast cancer Weekly on a PDA over 160 days. Patients asked to view videos on the PDA
about how to communicate about symptoms
and to bring the PDA to clinic appointments.
Professionals viewed symptom summaries on
the PDA and a printed output was added to
clinic notes.
Ruland 2010,37 Norway,
n=145 (CHOICE ITPA
intervention)
Inpatient and outpatient oncology.
Haematological malignancies
Preclinic assessments and daily
during inpatient admissions over
1 year
Symptom summaries printed and added to
clinical notes to be reviewed by the treating
physician
Trowbridge 1997,40 USA,
n=510
Outpatient oncology. Recurrent or
metastatic cancer
Questionnaire immediately before
a clinic appointment
Summary sheet provided to oncologist before
the appointment
Continued
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treating physicians and instructed patient’s not to take
their pain tools to clinic appointments; however, the
remainder of studies expected physicians to act on
patient-reported data, and therefore treating physi-
cians tended not to be blinded. In some studies con-
trols also monitored symptoms without feedback to
clinicians, and in the remainder controls received
usual care without additional pain monitoring.
The results of four studies should be interpreted
with caution. Aubin et al19 conducted a non-
randomised study which had high dropouts due
to death and hospital admission. The study by
Bertsche et al23 was also a non-randomised trial.
Methodological details were lacking in the studies by
Trowbridge et al40 and Vallières et al41 and the risk of
bias in these studies was unclear.
Table 2 Continued
Author, publication year,
country, number of
participants (n). Clinical setting Monitoring
PROM feedback mechanism (intervention
group)
Vallières 2006,41 Canada,
n=64
Outpatient radiation oncology.
Mixed cancer types
Twice daily paper diary at home
for 3 weeks
Participants asked to bring their diary to
scheduled clinic appointments. Participants
asked to seek medical attention if pain
intensity scores or analgesic use reached a
predetermined threshold
Velikova 2004,42 UK, n=286 Outpatient oncology. Mixed cancer
types
Touch screen questionnaires in
the waiting room before
appointments for 6 months
Specific symptoms and functional outcomes
were displayed individually and tracked
longitudinally on graphs provided to the
patient’s physician.
Wilkie 2010,45 USA, n=215 Outpatient oncology. Lung cancer Greased pencil on a laminated
pain tool on a daily basis
Patients watched a video on how to monitor
and report changes in pain, and encouraged to
summarise their pain ratings in note form to
help them verbally report pain at scheduled
appointments.
PDA, personal digital assistant; PROM, patient-reported outcome measurement.
Table 3 Risk of bias for the included studies
Random sequence
generation
Allocation
concealment
Blinding of outcome
assessment
Incomplete
outcome data
Selective
reporting
Other
bias
Anderson 2015 Yes Unclear Unclear Yes Yes Yes
Aubin 2006 Unclear Unclear Unclear Yes Unclear No
Berry 2011 Yes Yes Unclear Yes Yes Yes
Berry 2014 Yes Yes Unclear Yes Yes Yes
Bertsche 2009 No No No Yes Yes No
Cleeland 2011 Yes Yes No Yes Yes Yes
De Wit 2001 Unclear Unclear Unclear Yes Yes Unclear
Du Pen 1999 Yes Unclear Yes Unclear Yes Yes
Given 2004 Yes Yes Yes Yes Yes Yes
Hoekstra 2006 Unclear Unclear Unclear Unclear Yes Unclear
Kravitz 2011 Yes Yes Unclear Yes Yes Yes
Kroenke 2010 Yes Unclear Yes Yes Yes Yes
Miaskowski
2004
Unclear Unclear No Yes Yes Unclear
Mooney 2013 Yes Yes Yes Yes Yes Yes
Post 2013 Unclear Unclear Unclear Yes Yes Yes
Ruland 2010 Yes Yes Yes Yes Yes Yes
Rustoen 2012 Yes Unclear Unclear Yes Yes Unclear
Trowbridge
1997
Unclear Unclear No Unclear Unclear Unclear
Vallières 2006 Unclear Unclear No Unclear Unclear No
Van der Peet
2009
Yes Unclear Unclear Yes Yes Unclear
Velikova 2004 Yes Yes Yes Yes Yes Yes
Wilkie 2010 Yes Yes Yes Yes Yes Yes
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Theory, rationale and intervention components
The interventions and their components are sum-
marised in table 2. Wilkie et al45 based their coaching
intervention on Johnson’s46 behavioural system model
for nursing practice. No other interventions used a
specific behavioural theory to guide development,
although several trials29 34 39 used self-efficacy and
academic detailing theories to inform their
interventions.
PROM data collection
A variety of formats were used to allow patients to
report pain and other symptoms. Nine trials used pen
and paper,19 23 25 26 28 34 40 45 four used touch
screen devices or personal digital assistants to collect
the data,20 36 37 41 three used automated telephone
monitoring,17 18 35 one used web-based systems,21
and in two trials, the patient was interviewed by a
nurse27 or a health educator29 for the data. One study
offered a choice between automated telephone moni-
toring or online monitoring.33
Pain and symptom monitoring took place immedi-
ately before planned outpatient visits in five studies
without the option of home symptom monitor-
ing,20 29 37 40 42 and one study23 collected PROMs
during an inpatient stay. The remaining studies
offered the ability to monitor symptoms at home as
required, or at set intervals ranging from twice daily
to monthly.
Eight out of 22 studies focused on pain and analge-
sic monitoring alone and the remainder involved
other PROM measures such as mood, quality of life,
distress, and analgesic usage. Pain was often moni-
tored alongside other physical symptoms including:
nausea, vomiting, constipation, diarrhoea, fatigue,
appetite loss, sleep disturbance, cough, breathlessness,
fever and dry mouth.
PROM data usage and feedback mechanisms
The patient-reported outcome data were used in a
variety of ways. Summary data were given to a clini-
cian in advance of a consultation in eight
studies.17 20 21 28 36 37 40 42 None of the clinicians in
these studies were given specific instructions about
how to use the data except in the study by Vallières
et al,41 in which clinicians were asked to alter analge-
sics according to the WHO’s analgesic ladder.
Five studies17 21 27 29 34 used the patient-generated
data to target education on analgesic use, self-
management skills and communicating about pain.
Berry et al21 embedded automated tailored coaching
messages into their web-based intervention. The
coaching messages typically focused on how to com-
municate about unrelieved symptoms with profes-
sionals. Four interventions17 18 27 35 contained
automatic alerts to physicians based on predetermined
symptom thresholds. One study19 also used a
symptom threshold concept within their paper diary
intervention, instructing patients to contact their
nurse if pain intensity or analgesic use crossed a
threshold. Four studies23 26 27 33 linked patient-
reported data to specific management algorithms to
support clinical decision-making.
Intervention fidelity
Several interventions were not delivered as designed.
Mooney et al35 reported that only 20 of 167 (12%)
automated alerts to physicians of symptoms exceeding
a threshold resulted in a provider-initiated unscheduled
contact. Hoekstra et al28 reported that despite patients
being advised to take their symptom monitor to all
medical appointments, it was used in only 232 of 1291
(18%) consultations. Van der Peet et al44 found that 22
of 37 (59%) written recommendations to physicians
advising medication changes were ignored. In compari-
son, one study by Bertsche et al23 found that
algorithm-derived treatment recommendations were
fully accepted by physicians in 85% of cases.
Quantitative assessment of changes in pain intensity
Pain was self-rated on a numerical rating out of 10 by
intervention patients and controls at baseline and the
end of the study in 15 trials (Post et al36 provided pre-
viously unpublished data to allow comparison of
effect size in this review). Seven studies19 26 33 36 41 44
rated pain using the Brief Pain Inventory, one24 used
measures from the Amsterdam Pain Management
Index, one study17 used the MD Anderson symptom
inventory and one study45 used a validated 10 cm
visual analogue scale. Five trials28 29 34 35 39 used
simple non-validated numerical pain rating scales out
of 10 points.
Forest plots summarising average pain intensity
across 12 trials, and present pain across 3 trials are
shown in figures 2 and 3. Average pain refers to how
a patient feels their pain has been overall and is a spe-
cific item in the Brief Pain Inventory. Studies which
did not use the Brief Pain Inventory but provided a
report of overall/cumulative pain severity as reported
by the patient have been considered here under the
heading of average pain intensity.
A statistically significant reduction in average pain
intensity was found of around half a point out of 10,
mean difference −0.59 (95% CI −0.87 to −0.30).
Removing the non-randomised study by Aubin et al19
from the meta-analysis did not significantly alter this
result (mean difference −0.58 (95% CI −0.90 to
−0.26). The I2 statistic was 46% indicating moderate
heterogeneity, which was expected in view of the het-
erogeneity of the interventions. One study by Mooney
et al35 which had problems with fidelity appeared to
be an outlier on the forest plot. A sensitivity analysis
with this removed reduced the I2 statistic to 24%.
Three studies reported ‘present’ pain intensity, that is,
pain at the moment that it was being reported by the
patient. There was no significant difference in present
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pain intensity between control and intervention groups,
mean difference −0.20 (95% CI −0.89 to 0.49).
Narrative summary of other pain-related outcomes
Several studies included pain-related outcome measures
other than pain intensity. Full details of the results of
these outcome measures are included as an online
supplementary table in appendix 2. Six studies (detailed
in 10 reports) considered the effect of the PROMs on
the clinical consultation.20 22 29–32 37 42–43 45
Interventions were associated with more symptoms
being reported and/or more discussions specifically
about pain.
There was no evidence that opioid prescribing or
the pain management index (an estimate of adequacy
of analgesic prescription) was improved in the inter-
vention groups compared with controls.17 34 39 40 45
However, one study by Bertsche et al23 found signifi-
cant improvements in guideline adherence over the
intervention period.
Two studies17 18 reported reductions in the number
of pain threshold events over time in the intervention
group compared with the control group, but these
reductions only reached statistical significance in the
study by Cleeland et al.18 The most frequent clinical
response to pain threshold alerts in both studies17 18
was to reinforce existing management strategies.
DISCUSSION
Main findings
Feedback based on patient-reported pain outcomes
has been used to effect changes in pain management
in four main ways: (1) to provide reports about pain
and additional symptoms to professionals (with the
intention of increasing professional awareness of unre-
lieved pain and other problems); (2) to tailor patient
pain education about self-management strategies and
how to communicate about pain; (3) to prompt
contact between a patient and professional when pain
is above a set threshold; and (4) to link pain treat-
ments to the severity of pain experienced by the
patient via algorithmic management guidelines. Such
interventions currently have a statistically significant
but small effect (<1 point on a 0–10 points rating
scale) on patient-reported average pain intensity.
Previous reviews have shown that PROMs in oncol-
ogy can improve patient satisfaction with care and
consultation outcomes. This is the first review to have
shown a significant impact of PROMs on a symptom
outcome. However, it is accepted that for analgesics,
patients desire reductions in pain of at least 50%,
ideally experiencing no worse than mild pain.47 A
half-point improvement on a 10-point scale is not of
such a magnitude. However, as monitoring pain and
feeding this back to patients and/or professionals is
fairly simple, the technique should be considered as
part of more comprehensive programmes to tackle
cancer pain.
The process evaluations described in three studies
suggested that intervention fidelity was subopti-
mal,28 35 44 which is likely to have reduced the effec-
tiveness of interventions. Physicians failed to respond
to symptom alerts and patients failed to take their
data to consultations. Moreover, making professionals
Figure 3 Forest plot of present pain intensity.
Figure 2 Forest plot of average/overall pain intensity.
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aware of high levels of patient-reported pain did not
necessarily result in changes to analgesic prescribing.
It is unclear from the evidence in this review as to
why this might be the case. Previous studies have sug-
gested that physicians can have a preference for their
own judgement of symptoms over formal PROM
measures.48 Another possibility is that numerical
ratings of pain fail to take into consideration the com-
plexity of pain experiences and individual patient pre-
ferences for pain management, which can become
more apparent during the clinical consultation.
Qualitative studies have shown that patients often
manage pain around an acceptable level, and make
trade-offs between opioid side effects, physical activ-
ity, cognitive function and pain relief.49 The interven-
tions reviewed have not captured this complexity.
Strengths and limitations
This review was systematically conducted and identi-
fied trials spanning three decades. Twenty of the 22
trials included were RCTs and narrative description of
these trials has allowed the components of interven-
tions to be characterised. Despite the use of different
measures of pain, we were able to obtain and combine
pain data from 15 studies to allow for a meta-analysis
of PROMs on clinically relevant outcomes. The main
limitation of this review is that there were problems
with intervention and trial description in several trials
(table 3) which could have introduced bias. In addi-
tion, it is important to note that pain measurement
was not the principal focus of every study included in
this review. Some trials collected a range of symptoms
and quality of life data including pain, and fed that
back to patients and/or professionals. However, in all
trials, pain was specifically monitored and pain-related
outcomes were reported within the results, enabling
comparison of pain data within this review.
Implications for practice, policy and research
Interventions which use PROMs to inform cancer
pain management by patients and professionals show
promise, but their usefulness and impact on pain
might be enhanced if interventions are better designed
and delivered. Based on the narrative review and con-
sidering the main components described by original
study authors, we formulated a summary of the key
steps that are necessary in order for these type of
interventions to be effective (see figure 4). Arguably, a
key component is the feedback process between
patients and professionals and this requires further
attention. The majority of studies in this review pre-
sented professionals with pain measures or threshold
alerts without any instructions on how these measures
should be used. This represents a missed opportunity
since evidence-based cancer pain management guide-
lines exist to guide action.
CONCLUSIONS
Interventions which have used patient-reported mea-
surements to enhance the management of cancer-
related pain have achieved modest reductions in
cancer pain intensity. The studies demonstrate that
patients with cancer can provide their own data to
guide management. The challenges are to provide
effective transfer of information and to ensure clini-
cians act on this information in order to improve pain
control.
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Figure 4 Steps by which PROM interventions can alter
patient-reported pain intensity. PROM, patient-reported
outcome measurement.
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